Approval · Notice of Compliance 25942 · 2021
VISKAZIDE: Notice of Compliance 25942
Issued May 27, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25942
- Date
- May 27, 2021
- Company
- Xediton Pharmaceuticals Inc.Oakville, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in product ownership
Products in this notice
Medicinal ingredients
- HYDROCHLOROTHIAZIDE 25 MG per TAB
- PINDOLOL 10 MG per TAB
- HYDROCHLOROTHIAZIDE 50 MG per TAB